These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14750502)

  • 1. An all-atom solution-equilibrated model for human extrinsic blood coagulation complex (sTF-VIIa-Xa): a protein-protein docking and molecular dynamics refinement study.
    Venkateswarlu D; Duke RE; Perera L; Darden TA; Pedersen LG
    J Thromb Haemost; 2003 Dec; 1(12):2577-88. PubMed ID: 14750502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor.
    Carlsson K; Freskgård PO; Persson E; Carlsson U; Svensson M
    Eur J Biochem; 2003 Jun; 270(12):2576-82. PubMed ID: 12787023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent estimates of the structure of the factor VIIa (FVIIa)/tissue factor (TF) and factor Xa (FXa) ternary complex.
    Lee CJ; Chandrasekaran V; Wu S; Duke RE; Pedersen LG
    Thromb Res; 2010 Apr; 125 Suppl 1():S7-S10. PubMed ID: 20156644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural biology of factor VIIa/tissue factor initiated coagulation.
    Vadivel K; Bajaj SP
    Front Biosci (Landmark Ed); 2012 Jun; 17(7):2476-94. PubMed ID: 22652793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
    Prasad R; Sen P
    Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
    Rao LV; Ruf W
    Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
    Beeler DL; Aird WC; Grant MA
    J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
    Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
    J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.
    Ohkubo YZ; Morrissey JH; Tajkhorshid E
    J Thromb Haemost; 2010 May; 8(5):1044-53. PubMed ID: 20180816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular dynamics simulation study to understand the effect of cholesterol and tissue factor palmitoylation on tissue factor-factor VIIa-factor Xa ternary complex in different lipid environments.
    Banerjee S; Sen P
    J Thromb Haemost; 2023 Apr; 21(4):917-932. PubMed ID: 36696201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first epidermal growth factor-like domains of factor Xa and factor IXa are important for the activation of the factor VII--tissue factor complex.
    Ndonwi M; Broze G; Bajaj SP
    J Thromb Haemost; 2005 Jan; 3(1):112-8. PubMed ID: 15634274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model of a ternary complex between activated factor VII, tissue factor and factor IX.
    Chen SW; Pellequer JL; Schved JF; Giansily-Blaizot M
    Thromb Haemost; 2002 Jul; 88(1):74-82. PubMed ID: 12152682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
    Ashton AW; Boehm MK; Johnson DJ; Kemball-Cook G; Perkins SJ
    Biochemistry; 1998 Jun; 37(22):8208-17. PubMed ID: 9609717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
    Carlsson K; Persson E; Carlsson U; Svensson M
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
    Thiec F; Cherel G; Christophe OD
    J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz-1 domain.
    Augustsson C; Svensson A; Kjaer B; Chao TY; Wenjuan X; Krogh BO; Breinholt J; Clausen JT; Hilden I; Petersen HH; Petersen LC
    J Thromb Haemost; 2018 May; 16(5):893-904. PubMed ID: 29532595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.
    Sorensen AB; Tuneew I; Svensson LA; Persson E; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
    J Biol Chem; 2020 Jan; 295(2):517-528. PubMed ID: 31801825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
    Osterlund M; Persson E; Svensson M; Carlsson U; Freskgård PO
    Biochem Biophys Res Commun; 2005 Feb; 327(3):789-93. PubMed ID: 15649415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.